Author

Carlos Lamsfus Calle

Observed names: Calle, Carlos Lamsfus, Carlos Lamsfus-Calle, Lamsfus Calle, C., Lamsfus Calle, Carlos

Observed institutions: Universitätsklinikum Tübingen, German Center for Infection Research, University of Tübingen

ORCID: 0000-0002-6766-1765

Observed ORCID: 0000-0002-6766-1765

OpenAlex ID: A5069444301

Sterile protection against human malaria by chemoattenuated PfSPZ vaccine

2017 · Benjamin Mordmüller, Güzin Surat, et al. · Nature · 406

PDF

Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2

2021 · Peter G. Kremsner, Philipp Mann, et al. · Wiener klinische Wochenschrift · 199

PDF

First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria

2019 · Benjamin Mordmüller, Mihály Sulyok, et al. · Clinical Infectious Diseases · 154

PDF

Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres

2015 · Benjamin Mordmüller, Christian Supan, et al. · Malaria Journal · 145

PDF

DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection

2017 · Mihály Sulyok, Thomas Rückle, et al. · The Lancet Infectious Diseases · 103

PDF

Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial

2021 · Zita Sulyok, Rolf Fendel, et al. · Nature Communications · 55

PDF

A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection

2022 · Benjamin Mordmüller, Zita Sulyok, et al. · npj Vaccines · 51

PDF

Immunosuppression in Malaria: Do Plasmodium falciparum Parasites Hijack the Host?

2021 · Carlos Lamsfus Calle, Benjamin Mordmüller, et al. · Pathogens · 46

PDF

Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients

2021 · Thirumalaisamy P. Velavan, Salih Kuk, et al. · Scientific Reports · 22

PDF

Expansion of Functional Myeloid-Derived Suppressor Cells in Controlled Human Malaria Infection

2021 · Carlos Lamsfus Calle, Rolf Fendel, et al. · Frontiers in Immunology · 19

PDF

Slow clearance of histidine-rich protein-2 in Gabonese with uncomplicated malaria

2024 · Carlos Lamsfus Calle, Frieder Schaumburg, et al. · Microbiology Spectrum · 11

First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine Booster

2024 · Meral Esen, Johanna Fischer-Herr, et al. · Vaccines · 7

PDF

Mapping of safe and early chemo-attenuated live Plasmodium falciparum immunization identifies immune signature of vaccine efficacy

2020 · Steffen Borrmann, Zita Sulyok, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 5

PDF

Complete attenuation of Plasmodium falciparum sporozoites by atovaquone–proguanil

2025 · Steffen Borrmann, Zita Sulyok, et al. · EMBO Molecular Medicine · 4

PDF

Eosinophils, basophils and myeloid-derived suppressor cells in chronic Loa loa infection and its treatment in an endemic setting

2024 · Gerrit Burger, Rafiou Adamou, et al. · PLoS neglected tropical diseases · 4

Comparison of VPM1002 with BCG in the prevention of tuberculosis in newborn infants: a multicentre, double-blind, randomised, phase 3, non-inferiority trial

2026 · Videlis Nduba, Matsontso Mathebula, et al. · The Lancet Infectious Diseases

Complete attenuation of Plasmodium falciparum sporozoites by atovaquone–proguanil

2025 · Borrmann, Steffen, Sulyok, Zita, et al. · edoc Publication server (Humboldt University of Berlin)

Works count: 20

Citation count: 1,226

H-index: 11

I10-index: 11